These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37827293)

  • 21. Sarcoid Uveitis: An Intriguing Challenger.
    Allegri P; Olivari S; Rissotto F; Rissotto R
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888617
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of ocular sarcoidosis: severe, refractory, and prolonged inflammation.
    Suzuki K; Ishihara M; Namba K; Ohno S; Goto H; Takase H; Kawano S; Shibuya E; Hase K; Iwata D; Mizuuchi K; Kitaichi N; Mizuki N; Ishida S
    Jpn J Ophthalmol; 2022 Sep; 66(5):447-454. PubMed ID: 35727483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uveitis in sarcoidosis.
    Uyama M
    Int Ophthalmol Clin; 2002; 42(1):143-50. PubMed ID: 12189610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Uveitis as a presenting manifestation of sarcoidosis: clinical characteritics of a series of 23 cases].
    Pruna L; Angioi K; Robin A; Deibener J; Poirson A; Selton J; Mohamed S; Kaminsky P
    Rev Med Interne; 2012 Nov; 33(11):615-20. PubMed ID: 22763184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.
    Suhler EB; Lowder CY; Goldstein DA; Giles T; Lauer AK; Kurz PA; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Tessler HH; Smith JR; Rosenbaum JT
    Br J Ophthalmol; 2013 Apr; 97(4):481-6. PubMed ID: 23376607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repository Corticotropin Injection (Acthar
    Wirta D; McLaurin E; Ousler G; Liu J; Kacmaz RO; Grieco J
    Ophthalmol Ther; 2021 Dec; 10(4):1077-1092. PubMed ID: 34669183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uveitis in the Setting of Co-Existing Systemic Sarcoidosis and Multiple Sclerosis.
    Gnanaraj R; Shah AA; Palestine AG; Reddy AK
    Ocul Immunol Inflamm; 2024 Feb; 32(2):181-183. PubMed ID: 37467487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual outcome in ocular sarcoidosis: retrospective evaluation of risk factors.
    Miserocchi E; Modorati G; Di Matteo F; Galli L; Rama P; Bandello F
    Eur J Ophthalmol; 2011; 21(6):802-10. PubMed ID: 21374555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ocular Manifestations in Sarcoidosis].
    Walscheid K; Tappeiner C; Heiligenhaus A
    Klin Monbl Augenheilkd; 2016 May; 233(5):594-600. PubMed ID: 27187879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repository corticotropin injection (H.P. Acthar gel) for the treatment of sarcoidosis-induced hypercalciuria and vitamin D dysregulation: a pilot, open label study.
    Judson MA; Modi A; Ilyas F; Yucel R
    Sarcoidosis Vasc Diffuse Lung Dis; 2018; 35(3):192-197. PubMed ID: 32476902
    [No Abstract]   [Full Text] [Related]  

  • 31. Hydroxychloroquine Therapy in Sarcoidosis-Associated Uveitis.
    Bert A; El Jammal T; Kodjikian L; Gerfaud-Valentin M; Jamilloux Y; Seve P
    Ocul Immunol Inflamm; 2024 Feb; 32(2):154-160. PubMed ID: 36749910
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Combination ACTHar Gel and Tacrolimus in Treatment-Resistant Focal Segmental Glomerulosclerosis and Membranous Glomerulopathy.
    Tumlin J; Galphin C; Santos R; Rovin B
    Kidney Int Rep; 2017 Sep; 2(5):924-932. PubMed ID: 29270498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adrenocorticotropic hormone gel in the treatment of systemic lupus erythematosus: A retrospective study of patients.
    Li X; Golubovsky J; Hui-Yuen J; Shah U; Olech E; Lomeo R; Singh V; Busch H; Strandberg MJ; Strandberg K; Horowitz L; Askanase A
    F1000Res; 2015; 4():1103. PubMed ID: 27158444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sarcoidosis Presenting with Bilateral Optic Disc Edema as the Initial Presentation.
    Yildiz MB; Balci S; Ozcaliskan S; Vural ET
    J Coll Physicians Surg Pak; 2021 Jul; 31(7):861-863. PubMed ID: 34271794
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical manifestations and risk factors for poor visual outcomes of ocular sarcoidosis in Taiwan.
    Lai IW; Lin CP; Hsieh YT; Yeh PT
    J Formos Med Assoc; 2022 Aug; 121(8):1560-1566. PubMed ID: 35027256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uveitis in Sarcoidosis - Clinical Features and Comparison with Other Non-infectious Uveitis.
    Niederer RL; Sharief L; Tomkins-Netzer O; Lightman SL
    Ocul Immunol Inflamm; 2023 Feb; 31(2):367-373. PubMed ID: 35201961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sarcoid uveitis: Diagnostic and therapeutic update].
    Varron L; Abad S; Kodjikian L; Sève P
    Rev Med Interne; 2011 Feb; 32(2):86-92. PubMed ID: 20970226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sarcoidosis and uveitis.
    Jones NP
    Ophthalmol Clin North Am; 2002 Sep; 15(3):319-26, vi. PubMed ID: 12434480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporin A in the treatment of posterior uveitis.
    Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of cystoid diffuse macular edema after uveitis and cataract surgery with the carbonic anhydrase inhibitor acetazolamide (Diamox)].
    Schilling H; Pauleikhoff D; Schrenk M; Wessing A
    Klin Monbl Augenheilkd; 1993 Mar; 202(3):206-11. PubMed ID: 8510414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.